Novartis Partners with NHS UK to Address LDL-C in Patients with ASCVD

The company ‘Novartis’ has now reached a partnership with the NHS of United Kingdom as a part of the collaboration for pioneering a population health management approach for the purpose of addressing the elevated LDL-C in the patients that are eligible with the ASCVD (atherosclerotic cardiovascular disease) across the region of United Kingdom. The collaboration […]

Continue Reading